A fluoride-free gel that regrows tooth enamel has been moving through health feeds again this week, often described as a solution for cavities and sensitivity that a dentist could apply in minutes.
The underlying science is real and peer-reviewed. The framing is running well ahead of it.
The study was conducted on extracted human teeth in a laboratory. It has never been tested in a living mouth. It was published in Nature Communications in November 2025, not this month. The regenerated layer measured roughly 10 micrometers, compared with natural enamel, which reaches around 2,000 micrometers on a biting surface.
None of that makes the work unimportant. It makes the current claims premature.
What the Researchers Actually Did
A team at the University of Nottingham's School of Pharmacy and Department of Chemical and Environmental Engineering developed a gel built from engineered proteins called elastin-like recombinamers, designed to mimic amelogenin, the protein that guides enamel formation during infancy.
Researchers demineralized extracted human teeth, applied a single coating of the gel, let it dry, then immersed the teeth in controlled mineralization baths formulated to replicate the ionic environment of saliva.
The gel formed a thin layer that filled microscopic cracks and pores and then acted as a scaffold, drawing calcium and phosphate ions into organized crystal growth aligned with the existing tooth structure. That alignment is the technical claim, a process called epitaxial mineralization, and it distinguishes the approach from coatings that sit on top of a tooth.
The team also applied it to exposed dentine, the softer layer beneath enamel whose exposure produces the sharp pain of sensitivity, and reported growth of an enamel-like mineral layer.
Lead author Abshar Hasan, PhD, a postdoctoral fellow, said that when applied to demineralized enamel or exposed dentine, "the material promotes the growth of crystals in an integrated and organized manner," recovering the architecture of healthy enamel.
Mechanical testing under simulated brushing, chewing and acid exposure found the regenerated material behaved comparably to healthy enamel.
The Scale Problem Nobody Mentions
Here is the detail that changes how the result should be read.
A single application produced a mineralized layer of roughly 10 micrometers. Natural enamel on the chewing surface of a molar runs to approximately 2,000 micrometers.
That is not a rebuilt tooth. It is a thin repair to a surface. For early demineralization or an exposed dentine surface, a thin integrated layer may be exactly what is needed. For an actual cavity, it is not remotely the same thing as a filling, and the study did not test cavity prevention in people at all.
The comparison images that circulate widely came from a two-week treatment, not a single brief application, which is worth knowing when the coverage describes a procedure taking seconds.
Why This Is in Your Feed Again This Week
The paper appeared in Nature Communications on November 4 and 5, 2025. The University of Nottingham issued its announcement at that time.
The current wave traces to that same announcement recirculating through aggregator feeds in July 2026. Several outlets have republished it with a 2026 publication date attached, which is incorrect.
Nothing new has been published. No clinical trial results have been reported. Trials were described as scheduled to begin in 2026, and MedicalDaily found no published evidence that human testing has produced results.
Readers encountering this story for the second or third time are not seeing a development. They are seeing the same nine-month-old paper.
Who Stands to Benefit Commercially
This belongs in the open, because it does not appear in most of the coverage.
Hasan and senior author Alvaro Mata, chair in biomedical engineering and biomaterials, co-founded Mintech-Bio, a University of Nottingham spin-off created to commercialize the gel. Statements about the product being safe, rapidly applied, scalable and available to patients soon come from the researchers who hold a stake in the company bringing it to market.
That does not make those statements false. It makes them interested claims that require independent verification, which clinical trials are designed to provide and which have not yet been reported.
There is no commercial product. Nothing is available for purchase, at a dental office or otherwise.
What Works for Sensitive Teeth Right Now
For anyone reading this because their teeth hurt when they drink something cold, the practical options have not changed.
Desensitizing toothpastes containing potassium nitrate or stannous fluoride are the standard first step and generally require several weeks of consistent use before the effect is apparent. In-office fluoride varnish is an established professional treatment. Where gum recession is the cause, a dentist can assess whether a graft or a bonded restoration is appropriate.
Persistent or worsening sensitivity is worth an examination rather than self-management, because it can signal a cracked tooth, decay or an exposed root that will not improve with toothpaste.
For decay prevention, the evidence base still points to fluoride toothpaste, reducing the frequency of sugar and acid exposure, and regular professional care. People with concerns about fluoride can raise them with a dentist, who can discuss what the evidence supports for their situation.
Anyone waiting for this gel should treat it as a technology to watch across several years, contingent on trials, regulatory review, and pricing. It is not a reason to defer treatment for a symptomatic tooth now.
Cost is worth flagging early, because dental coverage is where this will land hardest. Most adult dental benefits in the United States are separate from medical insurance, and preventive treatments applied in an office are frequently paid out of pocket for adults even when covered for children. A novel product without an established billing code is likely to be a cash expense at first, which historically means the people with the most untreated decay are the last to get access. Readers with limited coverage can ask about dental schools, federally qualified health centers, and community clinics, which often provide preventive care on a sliding scale today.
MedicalDaily will report on results if human trial data are published.
Frequently Asked Questions
Is the research real? Yes. It was published in Nature Communications in November 2025 and is peer-reviewed.
Has it been tested in people? No. The study used extracted human teeth in laboratory conditions. There are no published results from testing in a living mouth.
How much enamel did it actually regrow? A single application produced a layer of roughly 10 micrometers. Enamel on a molar's biting surface is approximately 2,000 micrometers thick.
Can I buy it or get it at my dentist? No. There is no commercial product available.
Does it prevent cavities? That was not tested. The study examined mineral regrowth on demineralized enamel and exposed dentine in the lab, not cavity prevention in patients.
Why is it in the news again? The July 2026 coverage recirculates the original November 2025 university announcement. Some outlets have attached an incorrect 2026 publication date.
What should I do about tooth sensitivity now? Desensitizing toothpaste, professional fluoride varnish and a dental examination remain the established options. Persistent or worsening sensitivity warrants an appointment.
